Italy-based biotech company developing a nano-in-micro and lung-to-heart delivery platform
NanoPhoria has raised €84M across 1 funding round from 4 investors, most recently a Series A round in Oct 2025. Based in Milan, Italy; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-10-07 | Series A | €84M |
| CDP Venture Capital,Panakès Partners,Sofinnova Partners,XGEN Venture |
| View deal → |
